https://www.selleckchem.com/pr....oducts/pmsf-phenylme
Both non-sustained ventricular tachycardia of ≥4 beats and ≥20 PVCs/24 h independently predicted mortality in univariate and multivariate survival analyses, adjusted for all other univariate predictors of mortality as well as relevant clinical factors, including cancer stage and type, performance status (ECOG), prior potentially cardiotoxic anti-cancer drug therapy, coronary artery disease, potassium concentration, and haemoglobin (multivariate adjusted hazard ratios NSVT ≥4 beats [HR 1.76, p = 0.022], ≥20 PVC
Like
Comment
Share
